Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ACROBiosystems ACROBiosystems SARS-CoV-2 Nucleocapsid protein (R203M, D377Y), His Tag

Supplier:  ACROBiosystems NUNC52HN100UG

Encompass_Preferred

Recombinant Protein;100UG;SARS-CoV-2 Nucleocapsid protein (R203M, D377Y), His Tag (NUN-C52Hn) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 419 (Accession # QHO62115.1 (R203M, D377Y)). The mutations (R203M, D377Y) on nucleocapsid protein were identified in the SARS-CoV-2 variants which emerged in India (known as B.1.617).;This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 47.3 kDa. The protein migrates as 55-65 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.;Immobilized SARS-CoV-2 Nucleocapsid protein (R203M, D377Y), His Tag (Cat. No. NUN-C52Hn) at 1 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (Cat. No. NUN-S41A1) with a linear range of 0.2-1 ng/mL (QC tested).;Immobilized SARS-CoV-2 Nucleocapsid protein (R203M, D377Y), His Tag (Cat. No. NUN-C52Hn) at 1 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Nucleocapsid Antibody, Chimeric mAb, Human IgG1 (Cat. No. NUN-M223) w

Catalog No. 50-210-7012


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.